• Product nameAnti-SPTLC1 antibody
    See all SPTLC1 primary antibodies
  • Description
    Rabbit polyclonal to SPTLC1
  • Tested applicationsSuitable for: WB, ICC/IFmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Rabbit, Horse, Chicken, Guinea pig, Cow, Cat, Dog, Zebrafish
  • Immunogen

    Synthetic peptide corresponding to a region within internal sequence amino acids 216-265 (DLERLLKEQE IEDQKNPRKA RVTRRFIVVE GLYMNTGTIC PLPELVKLKY) of Human SPTLC1 (NP_006406).

  • Positive control
    • Human fetal brain lysate. This antibody gave a positive result when used in the following formaldehyde fixed cell lines: JEG3.



Our Abpromise guarantee covers the use of ab84585 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 1 µg/ml. Predicted molecular weight: 53 kDa. Good results were obtained when blocked with 5% non-fat dry milk in 0.05% PBS-T.
ICC/IF Use a concentration of 5 µg/ml.


  • FunctionSerine palmitoyltransferase (SPT). The heterodimer formed with LCB2 (SPTLC2 or SPTLC3) constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SSSPTA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC3-SSSPTA isozyme uses both C14-CoA and C16-CoA as substrates, with a slight preference for C14-CoA. The SPTLC1-SPTLC2-SSSPTB complex shows a strong preference for C18-CoA substrate, while the SPTLC1-SPTLC3-SSSPTB isozyme displays an ability to use a broader range of acyl-CoAs, without apparent preference.
  • Tissue specificityWidely expressed. Not detected in small intestine.
  • PathwayLipid metabolism; sphingolipid metabolism.
  • Involvement in diseaseDefects in SPTLC1 are the cause of hereditary sensory and autonomic neuropathy type 1A (HSAN1A) [MIM:162400]. The hereditary sensory and autonomic neuropathies are a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN1A is an autosomal dominant axonal neuropathy with onset in the second or third decades. Initial symptoms are loss of pain, touch, heat, and cold sensation over the feet, followed by distal muscle wasting and weakness. Loss of pain sensation leads to chronic skin ulcers and distal amputations.
  • Sequence similaritiesBelongs to the class-II pyridoxal-phosphate-dependent aminotransferase family.
  • Cellular localizationEndoplasmic reticulum membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • HSAN antibody
    • HSAN1 antibody
    • HSN1 antibody
    • LBC1 antibody
    • LCB 1 antibody
    • LCB1 antibody
    • Long chain base biosynthesis protein 1 antibody
    • MGC14645 antibody
    • Serine C palmitoyltransferase antibody
    • Serine palmitoyl CoA transferase 1 antibody
    • Serine palmitoyltransferase 1 antibody
    • Serine palmitoyltransferase long chain base subunit 1 antibody
    • Serine palmitoyltransferase subunit 1 antibody
    • Serine-palmitoyl-CoA transferase 1 antibody
    • SPT 1 antibody
    • SPT1 antibody
    • SPTC1_HUMAN antibody
    • SPTI antibody
    • SPTLC 1 antibody
    • SPTLC1 antibody
    see all

Anti-SPTLC1 antibody images

  • ICC/IF image of ab84585 stained JEG3 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody ab84585 at 5µg/ml overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti- rabbit (ab96899) IgG (H+L) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

  • Anti-SPTLC1 antibody (ab84585) at 1 µg/ml (in 5% skim milk / PBS buffer) + Human fetal brain lysate at 10 µg

    HRP conjugated anti-Rabbit IgG at 1/50000 dilution

    Predicted band size : 53 kDa
    Observed band size : 62 kDa (why is the actual band size different from the predicted?)
    Gel concentration: 12%

References for Anti-SPTLC1 antibody (ab84585)

ab84585 has not yet been referenced specifically in any publications.

Product Wall

Thank you for your phone call.

Expiration date: xxx

I am very pleased to hear you would like to accept our offer and test ab84585 in bovine. This code will give you: 1 free PRIMARY ANTIBODYbefore the expirat...

Read More